Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC (Q57069952)
Jump to navigation
Jump to search
scientific article published on 25 September 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC |
scientific article published on 25 September 2018 |
Statements
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC (English)
Scott J Antonia
Augusto Villegas
Davey Daniel
David Vicente
Shuji Murakami
Rina Hui
Takayasu Kurata
Alberto Chiappori
Ki H Lee
Maike de Wit
Byoung C Cho
Maryam Bourhaba
Xavier Quantin
Takaaki Tokito
Tarek Mekhail
David Planchard
Young-Chul Kim
Christos S Karapetis
Sandrine Hiret
Gyula Ostoros
Kaoru Kubota
Jhanelle E Gray
Luis Paz-Ares
Javier de Castro Carpeño
Martin Reck
Johan Vansteenkiste
David R Spigel
Catherine Wadsworth
Giovanni Melillo
Maria Taboada
Phillip A Dennis
Mustafa Özgüroğlu
PACIFIC Investigators